RedHill Biopharma reported $-1.54M in Net Income for its fiscal quarter ending in June of 2024.





Net Income Change Date
Cara Therapeutics USD -5.53M 621K Sep/2025
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD 56.84M 63.82M Dec/2025
Cronos Group USD -1.82M 24.14M Dec/2025
RedHill Biopharma USD -1.54M 0 Jun/2024